A Phase 4 Study Using a Test-Negative Design to Evaluate the Effectiveness Of A 20-Valent Pneumococcal Conjugate Vaccine against Vaccine-Type Radiologically-Confirmed Community acquired Pneumonia in Adults ≥ 65 Years of Age